Ifp Advisors, Inc Editas Medicine, Inc. Transaction History

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 5,036 shares of EDIT stock, worth $14,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,036

Previous 5,000 0.72%

Holding current value

$14,000

Previous $5,000 120.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$0.98 - $2.35 $35 - $84	36 Added 0.72%	5,036 $11,000
Q1 2025 May 05, 2025	BUY	$1.14 - $3.2 $5,661 - $15,891	4,966 Added 14605.88%	5,000 $5,000
Q4 2024 Feb 04, 2025	BUY	$1.2 - $3.76 $40 - $127	34 New	34 $0
Q2 2023 Aug 04, 2023	BUY	$6.36 - $11.47 $311 - $562	49 New	49 $0
Q4 2022 Feb 07, 2023	SELL	$8.32 - $13.21 $2,229 - $3,540	-268 Reduced 27.52%	706 $26,000
Q2 2022 Sep 06, 2022	BUY	$9.99 - $21.35 $9,730 - $20,794	974 New	974 $47,000
Q2 2022 Aug 12, 2022	SELL	$9.99 - $21.35 $9,730 - $20,794	-974 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$14.08 - $27.63 $11,503 - $22,573	817 Added 520.38%	974 $18,000
Q4 2021 Jan 12, 2022	SELL	$26.55 - $40.57 $1,380 - $2,109	-52 Reduced 24.88%	157 $5,000
Q3 2021 Oct 06, 2021	BUY	$39.27 - $72.94 $7,854 - $14,588	200 Added 2222.22%	209 $9,000
Q3 2020 Oct 29, 2020	SELL	$28.06 - $37.16 $28 - $37	-1 Reduced 10.0%	9 $0
Q1 2020 May 12, 2020	SELL	$14.88 - $32.78 $2,916 - $6,424	-196 Reduced 95.15%	10 $0
Q4 2019 Jan 17, 2020	SELL	$19.49 - $32.63 $12,785 - $21,405	-656 Reduced 76.1%	206 $6,000
Q3 2019 Nov 07, 2019	SELL	$22.49 - $26.81 $6,049 - $7,211	-269 Reduced 23.78%	862 $19,000
Q1 2019 May 15, 2019	BUY	$19.43 - $26.41 $2,234 - $3,037	115 Added 11.32%	1,131 $28,000
Q4 2018 Jan 23, 2019	BUY	$18.19 - $31.79 $2,983 - $5,213	164 Added 19.25%	1,016 $23,000
Q3 2018 Oct 25, 2018	SELL	$27.65 - $38.39 $718 - $998	-26 Reduced 2.96%	852 $0
Q2 2018 Aug 07, 2018	SELL	$31.4 - $41.01 $4,835 - $6,315	-154 Reduced 14.92%	878 $0
Q1 2018 Jun 03, 2019	BUY	$29.84 - $44.08 $5,371 - $7,934	180 Added 21.13%	1,032 $32,000
Q1 2018 May 09, 2018	SELL	$29.84 - $44.08 $5,371 - $7,934	-180 Reduced 17.44%	852 $0
Q4 2017 Jan 24, 2018	SELL	$21.89 - $31.34 $14,316 - $20,496	-654 Reduced 38.79%	1,032 $0
Q3 2017 Oct 30, 2017	BUY	$15.81 - $24.01 $20,553 - $31,213	1,300 Added 336.79%	1,686 $40,000
Q1 2017 Jun 03, 2019	SELL	N/A	-745 Reduced 65.87%	386 $9,000
Q1 2016 Jun 03, 2019	BUY	N/A	1,131	1,131 $28,000

Others Institutions Holding EDIT

# of Institutions

213

Shares Held

45.3M

Call Options Held

476K

Put Options Held

338K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $191M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account